Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism.

Idiopathic hypogonadotropic hypogonadism (IHH) due to defects of gonadotropin-releasing hormone (GnRH) secretion and/or action is a developmental disorder of sexual maturation. To date, several single-gene defects have been implicated in the pathogenesis of IHH. However, significant inter- and intrafamilial variability and apparent incomplete penetrance in familial cases of IHH are difficult to reconcile with the model of a single-gene defect. We therefore hypothesized that mutations at different IHH loci interact in some families to modify their phenotypes. To address this issue, we studied 2 families, one with Kallmann syndrome (IHH and anosmia) and another with normosmic IHH, in which a single-gene defect had been identified: a heterozygous FGF receptor 1 (FGFR1) mutation in pedigree 1 and a compound heterozygous gonadotropin-releasing hormone receptor (GNRHR) mutation in pedigree 2, both of which varied markedly in expressivity within and across families. Further candidate gene screening revealed a second heterozygous deletion in the nasal embryonic LHRH factor (NELF) gene in pedigree 1 and an additional heterozygous FGFR1 mutation in pedigree 2 that accounted for the considerable phenotypic variability. Therefore, 2 different gene defects can synergize to produce a more severe phenotype in IHH families than either alone. This genetic model could account for some phenotypic heterogeneity seen in GnRH deficiency.

[1]  W. Lim,et al.  Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT , 2003, Nature Genetics.

[2]  Joseph Schlessinger,et al.  Structure of the FGF Receptor Tyrosine Kinase Domain Reveals a Novel Autoinhibitory Mechanism , 1996, Cell.

[3]  N. Roux,et al.  Paediatric phenotype of Kallmann syndrome due to mutations of fibroblast growth factor receptor 1 (FGFR1) , 2006, Molecular and Cellular Endocrinology.

[4]  F. Torricelli,et al.  Expression and Function of Gonadotropin-releasing Hormone (GnRH) Receptor in Human Olfactory GnRH-secreting Neurons , 2004, Journal of Biological Chemistry.

[5]  E. Maestrini,et al.  A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules , 1991, Nature.

[6]  J. Hardelin,et al.  X chromosome-linked Kallmann syndrome: clinical heterogeneity in three siblings carrying an intragenic deletion of the KAL-1 gene. , 2003, The Journal of clinical endocrinology and metabolism.

[7]  E. Nieschlag,et al.  Hormone substitution in male hypogonadism , 2000, Molecular and Cellular Endocrinology.

[8]  Jimmy D Bell,et al.  Digenic inheritance of severe insulin resistance in a human pedigree , 2002, Nature Genetics.

[9]  G. Vannelli,et al.  Anosmin-1 Modulates Fibroblast Growth Factor Receptor 1 Signaling in Human Gonadotropin-Releasing Hormone Olfactory Neuroblasts through a Heparan Sulfate-Dependent Mechanism , 2004, The Journal of Neuroscience.

[10]  J. Weissenbach,et al.  The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules , 1991, Cell.

[11]  W. Crowley,et al.  The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics. , 2001, The Journal of clinical endocrinology and metabolism.

[12]  D. Kassel,et al.  Characterization of pp60c-src tyrosine kinase activities using a continuous assay: autoactivation of the enzyme is an intermolecular autophosphorylation process. , 1995, Biochemistry.

[13]  F. Speleman,et al.  Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome , 2003, Nature Genetics.

[14]  W. Crowley,et al.  Reversible kallmann syndrome, delayed puberty, and isolated anosmia occurring in a single family with a mutation in the fibroblast growth factor receptor 1 gene. , 2005, The Journal of clinical endocrinology and metabolism.

[15]  B. Olwin,et al.  Cell type and tissue distribution of the fibroblast growth factor receptor , 1989, Journal of cellular biochemistry.

[16]  C. Petit,et al.  Kallmann Syndrome: Mutations in the Genes Encoding Prokineticin-2 and Prokineticin Receptor-2 , 2006, PLoS genetics.

[17]  Genetic and mutational analyses of a large multiethnic Bardet-Biedl cohort reveal a minor involvement of BBS6 and delineate the critical intervals of other loci. , 2001, American journal of human genetics.

[18]  S. O’Rahilly,et al.  The GPR54 Gene as a Regulator of Puberty , 2003 .

[19]  N. Katsanis,et al.  Human genetics and disease: Beyond Mendel: an evolving view of human genetic disease transmission , 2002, Nature Reviews Genetics.

[20]  P. Chanson,et al.  A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. , 1997, The New England journal of medicine.

[21]  V. P. Eswarakumar,et al.  Cellular signaling by fibroblast growth factor receptors. , 2005, Cytokine & growth factor reviews.

[22]  J. Stephens,et al.  A neurophysiological study of mirror movements in adults and children , 1999, Annals of neurology.

[23]  Robert J Linhardt,et al.  Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain. , 2006, Genes & development.

[24]  E. Génin,et al.  Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Rifkin,et al.  Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. , 1994, The Journal of biological chemistry.

[26]  T. Dryja,et al.  Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci. , 1994, Science.

[27]  M. de Castro,et al.  Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia. , 2006, The Journal of clinical endocrinology and metabolism.

[28]  Mary G. Lin,et al.  FGF signaling through FGFR1 is required for olfactory bulb morphogenesis , 2003, Development.

[29]  W. Crowley,et al.  Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[30]  S. Seminara,et al.  Characterization of the human nasal embryonic LHRH factor gene, NELF, and a mutation screening among 65 patients with idiopathic hypogonadotropic hypogonadism (IHH) , 2004, Journal of Human Genetics.

[31]  S. Werner,et al.  Targeted expression of a dominant-negative fibroblast growth factor (FGF) receptor in gonadotropin-releasing hormone (GnRH) neurons reduces FGF responsiveness and the size of GnRH neuronal population. , 2005, Molecular endocrinology.

[32]  M. Jaye,et al.  Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction , 1996, Molecular and cellular biology.

[33]  W. Crowley,et al.  Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism. , 2001, The Journal of clinical endocrinology and metabolism.

[34]  S. Moenter,et al.  Developmental regulation of gonadotropin-releasing hormone neurons by fibroblast growth factor signaling. , 2004, Endocrinology.

[35]  S. Antonarakis.  Recommendations for a nomenclature system for human gene mutations , 1998 .

[36]  E. Milgrom,et al.  The same molecular defects of the gonadotropin-releasing hormone receptor determine a variable degree of hypogonadism in affected kindred. , 1999, The Journal of clinical endocrinology and metabolism.

[37]  E. Fliers,et al.  Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes , 2006, Molecular and Cellular Endocrinology.

[38]  W. Crowley,et al.  Successful use of pulsatile gonadotropin-releasing hormone (GnRH) for ovulation induction and pregnancy in a patient with GnRH receptor mutations. , 2000, The Journal of clinical endocrinology and metabolism.

[39]  A. Becchetti,et al.  Neuroblast long-term cell cultures from human fetal olfactory epithelium respond to odors , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[40]  T. Ogata,et al.  Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients. , 2004, The Journal of clinical endocrinology and metabolism.

[41]  J. Boudreaux,et al.  The rat osteocalcin fibroblast growth factor (FGF)-responsive element: an okadaic acid-sensitive, FGF-selective transcriptional response motif. , 1996, Molecular endocrinology.

[42]  S. Wray.  Molecular mechanisms for migration of placodally derived GnRH neurons. , 2002, Chemical senses.

[43]  P. Bouloux,et al.  Heterogeneity in the mutations responsible for X chromosome-linked Kallmann syndrome. , 1993, Human molecular genetics.

[44]  S. Wray,et al.  Novel gene expressed in nasal region influences outgrowth of olfactory axons and migration of luteinizing hormone-releasing hormone (LHRH) neurons. , 2000, Genes & development.

[45]  S. Mcconnell,et al.  Fgf8 expression defines a morphogenetic center required for olfactory neurogenesis and nasal cavity development in the mouse , 2005, Development.

[46]  M. Parisi,et al.  Genetics of Hirschsprung disease , 2000, Current opinion in pediatrics.

[47]  J. Hardelin,et al.  Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2) , 2005, Human mutation.

[48]  G. Martin,et al.  An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination , 1998, Nature Genetics.